genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Eli Lilly
Eli Lilly Plans $400M Manufacturing Expansion
Bioprocessing
FUJIFILM Expands its Gene Therapy Services
News
Gut Microbiota Imbalance Linked with Epigenetic Changes, Promotes Colorectal Cancer
Genetics
Key Genetic Regulators of Parkinson’s Disease Identified
Vertex Pharmaceuticals
CRISPR Therapeutics, Vertex Report First Data from Trials of Gene-Editing Treatment…
Insights
Bioprocessing
Gene Therapy Companies’ Demands Reshape CDMOs
Bioprocessing
Building Bioprocessing from Data
Cell Therapy
“Squeezing” Cells Could Transform Cell Therapy Manufacturing
Insights
2020 Vision: Predictions of What May Shape Precision Medicine
Insights
How to Use CRISPR for Site-Specific Epigenetic Editing in the Nervous…
A-Lists
Drug Discovery
Top 10 Pharma Companies of 2019
A-Lists
Top 25 Biotech Companies of 2019
Insights
Top 10 Asia Biopharma Clusters 2019
Brexit
Top 10 European Biopharma Clusters
GEN Edge
Top 10 U.S. Biopharma Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Eli Lilly
Eli Lilly Plans $400M Manufacturing Expansion
Bioprocessing
FUJIFILM Expands its Gene Therapy Services
Bioprocessing
Gene Therapy Companies’ Demands Reshape CDMOs
Bioprocessing
Building Bioprocessing from Data
Magazine
November 2019 Vol. 39 No. 11
Synthetic Biology Seizes New Ground in Healthcare
November 2019 Vol. 39 No. 11
Agrigenomics Yields a Next-Gen Cornucopia
November 2019 Vol. 39 No. 11
Protein-Protein Interactions Get a New Groove On
Commentary
Machine Learning Enhances Cytometry Analysis
November 2019 Vol. 39 No. 11
Biomarker Specialists Team Up, Run Up the Companion Diagnostics Score
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
eBooks
Detecting HCP Impurities in the Bioproduction Haystack
Posters
Inertial Microfluidics Enables Highly Consistent Separation and Concentration of Leukocytes from…
Upcoming Webinars
Shake-Up Your Cell Expansion Efforts
Upcoming Webinars
Smarter Biobank Management
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Rare and Neglected Diseases
Rare and Neglected Diseases
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Rare and Neglected Diseases
Celgene, Acceleron Win FDA OK for Drug to Treat Anemia in Adults with Beta Thalassemia
Rare and Neglected Diseases
FDA Places Partial Clinical Hold on Some Trials of Novartis Gene Therapy
Rare and Neglected Diseases
Schistosome Parasite Paralyzed by Chemical Produced by Tiny Aquatic Animal
Rare and Neglected Diseases
Alexion to Acquire Achillion for $930M+, Expanding Rare Disease Portfolio
Rare and Neglected Diseases
UCB to Acquire Ra Pharma for $2.1B, Raising Rare Disease Presence
Rare and Neglected Diseases
Lonza, Prevail Therapeutics Partner on Gene Therapy Manufacturing
Rare and Neglected Diseases
Deep Genomics Identifies AI-Discovered Candidate for Wilson Disease
Rare and Neglected Diseases
Passage Bio Licenses Gene Therapy Candidate for CMT2A from Penn, Days...
Rare and Neglected Diseases
Sumitomo Dainippon Commits $3B toward Alliance with Roivant
Rare and Neglected Diseases
Acer Therapeutics Axes 60% of Workforce after FDA Rebuff
Rare and Neglected Diseases
Amicus, Thermo Fisher’s Brammer Bio Partner on Gene Therapy Manufacturing
Rare and Neglected Diseases
Vertex Grows Gene Editing Presence, Acquiring Exonics and Expanding CRISPR Therapeutics...
Rare and Neglected Diseases
Orchard Therapeutics Licenses MPS-I Gene Therapy from SR-TIGET
Rare and Neglected Diseases
Gilead Sciences Launches Up-to-$2B Kidney Disease Partnership with Goldfinch Bio
Rare and Neglected Diseases
Pfizer to Acquire Therachon for Up to $810M, Expanding Rare Disease...
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
